Dynamics of B Cell Recovery In Kidney/Bone Marrow Transplant Recipients

Abstract

Background Previous studies identified B cell gene signatures and predominance of specific B cell subsets as a marker of operational tolerance following kidney transplantation. These findings suggested a role for B cells in the establishment or maintenance of tolerance. Here we analyzed B cell recovery in 4 subjects, 3 of whom achieved tolerance after combined kidney/bone marrow transplantation. Methods Peripheral B cell subsets were examined longitudinally by flow cytometry. Immunoglobulin heavy chain repertoire analysis was performed using next generation sequencing. Lastly, the patients’ serum reactivity to HLA was assessed by Luminex. Results B cell counts recovered approximately 1 year posttransplant except for 1 subject who experienced delayed reconstitution. This subject resumed immunosuppression for acute rejection at 10 months posttransplant and underwent preemptive retransplantation at 3 years for chronic rejection. B cell recovery was accompanied by a high frequency of CD20+CD24highCD38high transitional B cells and a diversified clonal repertoire. However, all 4 subjects showed prevalence of CD20+CD27+ memory B cells around 6 months posttransplant when B cell counts were still low and the clonal B cell repertoire very limited. The predominance of memory B cells was also associated with high levels of somatically mutated IGHV sequences and transient serum reactivity to HLA. Conclusions Our observations reveal the presence of memory B cells early posttransplant that likely escaped the preparative regimen at a time consistent with the establishment of tolerance. Further studies are warranted to characterize the functional properties of these persisting memory cells and evaluate their potential contribution to tolerance induction.

Rejection of xenogeneic porcine islets in humanized mice is characterized by graft-infiltrating Th17 cells and activated B cells

“…Reconstitution of the B cell pool after anti‐CD20 therapy occurs over a variable period of time depending on the species: for instance, murine B cell reconstitution can start as early as 4 weeks, although human B cell recovery begins over a span of 6‐12 months . Despite these kinetic differences, an interesting phenomenon described in both animals and humans is a preponderance of circulating TrBs during the reconstitution phase after anti‐CD20 therapy . In agreement with findings from other studies, we observed that rituximab induced a predominance of TrBs in the circulation of treated subjects.…”

T‐cell receptor and B‐cell receptor repertoire profiling in adaptive immunity

“…B cell receptor repertoire reconstruction after CKBMT in four patients showed that the diversity of B‐cell receptors in graft‐tolerant subjects recovered to pre‐transplant levels after 1 year post‐transplantation.…”

Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV Disease

“…In other conditions of hematopoietic cell recovery such as kidney or bone marrow transplantation, low B-cell counts are associated with slow B-cell reconstitution ( 62 , 63 ). In contrast, in our cohort, low B-cell counts pre-ART were rapidly normalized post-ART, suggesting a different mechanism of B-cell reconstitution than that reported for transplant recipients.…”